Altasciences Participates in Clinical Trial for Type 1 Diabetes Mellitus
Altasciences is pleased to have partnered with Xeris Pharmaceuticals, a specialty pharmaceutical company leveraging its novel formulation technology platforms to…
Janssen to begin phase 2 clinical trials of Hanmi Pharma’s diabetes drug
US pharmaceutical company Janssen will start carrying out phase 2 clinical trials in the US to evaluate the efficacy and…
Sanofi’s Toujeo® met main objective in head-to-head study versus insulin degludec
Sanofi’s Toujeo® met the primary study objective in the first large head-to-head clinical trial1, called BRIGHT study, comparing Toujeo with…
Xultophy® reported a better option than basal-bolus insulin therapy to manage type 2 diabetes by participants in the DUAL VII clinical trial
Once-daily Xultophy® (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen).…
Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes
Imcyse, a biotechnology company developing active specific therapies for the treatment of severe chronic diseases, today announces that it began…